Search Results for: charles raubicheck

Charles Raubicheck, head of our firm’s FDA practice, will chair a panel and deliver an address at the “U.S. & Brazil Conference: Navigating New Frontiers in Pharmaceutical, Medical Device and Food Law and Regulation,” to be held on September 10-11, 2012 in Sao Paolo, Brazil. The conference, sponsored by The Food and Drug Law Institute […]

PIVDisputes2011 On May 2-4, Frommer Lawrence & Haug will co-chair and co-sponsor the Fifth Anniversary Paragraph IV Disputes Conference in New York. On May 3-4, FLH Managing Partner Edgar H. Haug will Co-Chair the Conference. On May 2, Partner Brian J. Malkin will speak on “Exploring Patent Term Adjustment and Patent Term Extensions and Understanding […]

PIVDisputes2011 Frommer Lawrence & Haug will co-chair and co-sponsor the Fifth Anniversary Paragraph IV Disputes Conference in New York on May 2-4. FLH Managing Partner Edgar H. Haug will Co-Chair the Conference. Partner Brian J. Malkin will speak on “Exploring Patent Term Adjustment and Patent Term Extensions and Understanding their Applicability to Drugs and Biologics” […]

On June 21-22, Frommer Lawrence & Haug will co-sponsor the first major biosimilar / follow-on biologics event hosted by the American Conference Institute in New York. Partners Charles J. Raubicheck and Brian J. Malkin will speak on key regulatory topics for obtaining approval of biosimilars, including demonstrating “interchangeability” with the reference biological and developing alternative […]

FLH partners Charles J. Raubicheck and Brian J. Malkin will be attending the upcoming Food and Drug Law Institute’s Annual Conference on April 22-23, 2010 in Washington, D.C. The Conference is scheduled to include updates from all of FDA’s centers, including major addresses by FDA Commissioner Margaret A. Hamburg, M.D., FDA’s Chief Counsel, Ralph S. […]

FLH Partner Charles J. Raubicheck, head of our firm’s FDA/Regulatory practice, will moderate a panel and deliver an address at the upcoming Food and Drug Law Institute’s Conference “U.S. & Brazil: Navigating New Frontiers in Pharmaceutical, Medical Device and Food Law and Regulation.” The conference will be held on September 10-11, 2012 in São Paolo, […]

FDA Lawyers Blog is proud to announce that for six years years running, FLH Partner Charles J. Raubicheck as been recognized as an FDA “Super Lawyer” in Thompson Reuter’s Super Lawyers publication for the New York Metro area. The process to become a “Super Lawyer” begins with peer nominations, then candidate research, and ends with […]

 Attorneys at FLH have actively followed the development of biosimilars legislation and have written on the topic in a number of forums. Some of our publications include: Brian J. Malkin, Challenges to the Development of a Biosimilars Industry in the United States, Recent Developments in Food and Drug Law, Aspatore / Thompson Reuters (2013 Edition) […]

Frommer Lawrence & Haug LLP (“FLH”) will attend the Biotechnology Industry Organization’s (“BIO’s”) International Convention this year, to be held in Washington, D.C on June 27-30. Come visit FLH at Booth 2857, where FLH will feature information about Life Sciences at FLH, including a number of articles and presentations on biotechnology authored or presented by […]